Regulating Human Embryonic Stem Cell in China

Beschreibung

The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal control are inefficient and ineffective way to monitoring human embryonic stem cell research.  The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. 
The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions.  The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonic stem cell research.
The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal funding control are inefficient and ineffective way to monitoring human embryonic stem cell research.  The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. 
The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions.  The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonicstem cell research.
The first book to cover comprehensive analysis of the EU, US and China patent system as applied to Human Embryonic Stem Cell related Inventions Comparatively discusses the moral status of human embryo in the EU, US and China Observes “stem cell tourism” phenomenon in China and finds inconsistent moral standards between patent law and practical application in China Offers the regulatory governance of human embryonic stem cell research in China, setting out a feasible approach to monitoring stem cell research in China Draws lessons from EU harmonization of human embryonic stem cell related regulation, and considers the reconciliation of human embryonic stem cell regulation at the international level Includes supplementary material: sn.pub/extras

Autor*in

Li Jiang

Themen in »Regulating Human Embryonic Stem Cell in China«

Human Embryonic Stem Cell The Patentability Human Embryonic Stem Cell Morality of human embryo Legal status of human embryo Stem Cell Tourism Phenomenon Stem Cell Therapy in China Harmonization Legal Diversity Legal Inconsistency Reconciliation

Stimmen zu »Regulating Human Embryonic Stem Cell in China«

Details

Link teilen